Claret Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $213K | Sell |
|
|||||
|
2022
Q2 | $261K | Sell |
|
|||||
|
2022
Q1 | $315K | Sell |
|
|||||
|
2021
Q4 | $386K | Sell |
|
|||||
|
2021
Q3 | $594K | Sell |
|
|||||
|
2021
Q2 | $818K | Sell |
|
|||||
|
2021
Q1 | $1.13M | Sell |
|
|||||
|
2020
Q4 | $1.22M | Sell |
|
|||||
|
2020
Q3 | $2.1M | Sell |
|
|||||
|
2020
Q2 | $3.84M | Sell |
|
|||||
|
2020
Q1 | $4.6M | Sell |
|
|||||
|
2019
Q4 | $7.25M | Sell |
|
|||||
|
2019
Q3 | $6.52M | Sell |
|
|||||
|
2019
Q2 | $7.9M | Sell |
|
|||||
|
2019
Q1 | $10.2M | Sell |
|
|||||
|
2018
Q4 | $7.98M | Buy |
|
|||||
|
2018
Q3 | $9.27M | Buy |
|
|||||
|
2018
Q2 | $10.9M | Buy |
|
|||||
|
2018
Q1 | $9.13M | Sell |
|
|||||
|
2017
Q4 | $9.82M | Buy |
|